These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 891492)

  • 41. Protein binding and CSF penetration of phenytoin following acute oral dosing in man.
    Brodie MJ; Muir SE; Agnew E; MacPhee GJ; Volo G; Teasdale E; MacPherson P
    Br J Clin Pharmacol; 1985 Feb; 19(2):161-8. PubMed ID: 3986076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of phenytoin and lamotrigine treatment on serum BDNF levels in offsprings of epileptic rats.
    Soysal H; Doğan Z; Kamışlı Ö
    Neuropeptides; 2016 Apr; 56():1-8. PubMed ID: 26706181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Action of diphenylhydantoin on chromosomes].
    Caratzali A; Roman IC
    C R Acad Hebd Seances Acad Sci D; 1971 Jan; 272(4):663-4. PubMed ID: 4995034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Cioczek JD; Kocharov SL; Andres-Mach M; Kominek M; Zolkowska D
    Eur J Pharmacol; 2010 Dec; 648(1-3):74-9. PubMed ID: 20826140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucocorticoid receptor IB: mediator of anti-inflammatory and teratogenic functions of both glucocorticoids and phenytoin.
    Katsumata M; Gupta C; Goldman AS
    Arch Biochem Biophys; 1985 Dec; 243(2):385-95. PubMed ID: 2867743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diphenylhydantoin potency and plasma protein binding.
    Shoeman DW; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Oct; 195(1):84-6. PubMed ID: 1181407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum acetone and liver acetone monooxygenase activity in pregnant rats, fetuses, and neonates: reversible pretranslational reduction of cytochrome P450IIE1 (P450IIE1) during pregnancy.
    Casazza JP; Sohn DH; Park KS; Song BJ
    Arch Biochem Biophys; 1994 Feb; 309(1):111-6. PubMed ID: 8117100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution and metabolism of diphenyl-hydantoin- 14 C in fetal and maternal tissues of the pregnant mouse.
    Waddell WJ; Mirkin BL
    Biochem Pharmacol; 1972 Feb; 21(4):547-52. PubMed ID: 5014511
    [No Abstract]   [Full Text] [Related]  

  • 49. Potentiation of the teratogenic effects and altered disposition of diphenylhydantoin in mice fed a purified diet.
    McClain RM; Rohrs JM
    Toxicol Appl Pharmacol; 1985 Jan; 77(1):86-93. PubMed ID: 3966245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4.
    Komatsu T; Yamazaki H; Asahi S; Gillam EM; Guengerich FP; Nakajima M; Yokoi T
    Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The metabolism of 5,5-diphenylhydantoin (DPH) in nonpregnant and pregnant Rhesus monkeys.
    Gabler WL; Hubbard GL
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):72-91. PubMed ID: 4199058
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of isoniazid on the metabolism of 14C-diphenylhydantoin in rats.
    Buttar HS; Wong LT; Moffatt JH
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):9-18. PubMed ID: 736695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of pregnancy or treatment with cetain steroids on N,N-dimethylaniline demethylation and N-oxidation by rabbit liver or lung microsomes.
    Devereux TR; Fouts JR
    Drug Metab Dispos; 1975; 3(4):254-8. PubMed ID: 240654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of estradiol-17 beta treatment on the metabolism and biliary excretion of phenytoin in the isolated perfused rat liver and in vivo.
    Vore M; Montgomery C
    J Pharmacol Exp Ther; 1980 Oct; 215(1):71-6. PubMed ID: 7452491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation.
    Finnell RH; Bennett GD; Slattery JT; Amore BM; Bajpai M; Levy RH
    Teratology; 1995 Dec; 52(6):324-32. PubMed ID: 8711619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin.
    Billings RE
    J Pharmacol Exp Ther; 1983 Jun; 225(3):630-6. PubMed ID: 6864524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of salicylamide on the placental transfer and fetal tissue distribution of sodium-35S-sulfate in the rat.
    Knight E; Van Wart J; Roe DA
    J Nutr; 1978 Feb; 108(2):216-25. PubMed ID: 621578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of pregnancy on the pharmacokinetics of phenytoin in rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1984 May; 229(2):351-8. PubMed ID: 6716263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
    Wells PG; Zubovits JT; Wong ST; Molinari LM; Ali S
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of folic acid on phenytoin kinetics in healthy subjects.
    Furlanut M; Benetello P; Avogaro A; Dainese R
    Clin Pharmacol Ther; 1978 Sep; 24(3):294-7. PubMed ID: 688723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.